Current and future therapies for type 1 diabetes | SpringerLink
2 Medikamentöse Therapie des Glukosestoffwechsels — Leitlinien.de
GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet? - The Lancet Diabetes & Endocrinology
Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect
Treatment of Type 2 Diabetes mellitus (T2DM): Can GLP-1 Receptor Agonists fill in the gaps? | Sharma | Chemical Biology Letters
Glucagon-like Peptide (GLP-1) and the treatment of diabetes - YouTube
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes | Nature Reviews Nephrology
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes, the ADJUNCT ONE™ treat-to-target randomised trial - Media Centre | EASD
Type 2 Diabetes and the Role of GLP-1 | Diabetes Education for Patients | novoMEDLINK™
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes: Molecular Therapy
Diabetes mellitus Typ 1: Add-on-Therapie zu Insulin im Blick
GLP-1R and Diabetes
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors | The Review of Diabetic Studies
GLP-1 receptor agonists and type 1 diabetes - DiabetesontheNet
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
GLP-1 Agonists in Type 1 Diabetes Mellitus | Semantic Scholar
Biomedicines | Free Full-Text | Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases
GLP-1 Agonist Effects on Glucagon Suppression
GLP-1: Actions on Beta-cell Mass and Function
In type 1 patients with residual ß-cell function, GLP-1 treatment... | Download Scientific Diagram
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
GLP-1-Rezeptoragonisten (Inkretinmimetika) | Gelbe Liste
Clinical Trial Tests Efficacy of Short-Acting GLP-1 Receptor Agonist in Type 1 Diabetes
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus | NEJM
Mini‐review: Glucagon responses in type 1 diabetes – a matter of complexity - Bisgaard Bengtsen - 2021 - Physiological Reports - Wiley Online Library
Welche Ursachen hat Diabetes? euroClinix® informiert
